|
CN112076168A
|
|
Roxithromycin dispersible tablet and preparation method thereof
|
|
CN111738658A
|
|
Pharmaceutical preparation management method
|
|
CN111551651A
|
|
Method for detecting impurity K in valsartan pharmaceutical composition
|
|
CN110946860A
|
|
Composition containing omeprazole sodium and preparation method thereof
|
|
CN110934834A
|
|
Voriconazole-containing composition and preparation method thereof
|
|
CN111172231A
|
|
Voriconazole microorganism limit inspection method
|
|
CN110501436A
|
|
In relation to the detection method of substance in Tinidazole pharmaceutical composition
|
|
CN108000439A
|
|
For opening the valve opening machine of closed container valve
|
|
CN108220389A
|
|
The assay method of urokinase potency
|
|
CN107860814A
|
|
A kind of protein isoelectric focusing electrophoresis method and its with adhesive dispenser
|
|
CN107638386A
|
|
A kind of kanamycin sulfate injection liquid and preparation method thereof
|
|
CN106501415A
|
|
A kind of content assaying method of sodium ferulate, aspirin, cinnarizine and vitamin B1
|
|
CN105944084A
|
|
Nerve growth factor composition and preparation method thereof
|
|
CN104547436A
|
|
Borning traditional Chinese medicinal composition capsule and preparation method thereof
|
|
CN104116718A
|
|
Itopride hydrochloride oral preparation
|
|
CN104116917A
|
|
Oral preparation of colloidal bismuth subcitrate
|
|
CN104027343A
|
|
Oral preparation of roxithromycin
|
|
CN104056058A
|
|
Oral preparation containing composition of bismuth potassium citrate, 3,4-difluorobenzonitrile and clarithromycin
|
|
CN104031901A
|
|
Method of purifying urokinase
|
|
CN103405462A
|
|
Compound capsule containing ilaprazole composition and preparation method thereof
|
